KALA BIO
KALA
97 hedge funds and large institutions have $171M invested in KALA BIO in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 14 reducing their positions, and 24 closing their positions.
164% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 14
56% more call options, than puts
Call options by funds: $2.74M | Put options by funds: $1.76M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
8% less funds holding
Funds holding: 106 → 97 (-9)
31% less capital invested
Capital invested by funds: $249M → $171M (-$77.5M)
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.53M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$2.47M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.81M |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$1.73M |
| 5 |
State Street
Boston,
Massachusetts
|
+$770K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$23.3M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$5.3M |
| 3 |
Millennium Management
New York
|
-$4.24M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.62M |
| 5 |
Two Sigma Advisers
New York
|
-$2.2M |
KALA Hedge Fund Activity: Q2 2021 in Review
97 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2021, worth a combined $171M — down 31% from $249M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of KALA and 15 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 37 added.
The largest buyer was BlackRock, adding an estimated $2.53M. The largest seller was Eventide Asset Management, exiting entirely with an estimated $23.3M sold.
- 97 institutional investors held KALA BIO (KALA) as of Q2 2021, down from 106 in Q1 2021.
- Funds reported $171M of KALA BIO stock for Q2 2021, down 31% quarter-over-quarter.
- 15 funds opened new KALA BIO positions in Q2 2021 and 24 closed out, a net change of -9 holders.
- The largest KALA BIO buyer in Q2 2021 was BlackRock, an estimated $2.53M added.
- The largest KALA BIO seller in Q2 2021 was Eventide Asset Management, an estimated $23.3M sold.
Based on aggregated 13F filings for Q2 2021.